Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UMN Pharma Inc.

www.umnpharma.com

Latest From UMN Pharma Inc.

Astellas Builds Vaccine Portfolio With Affinivax Pneumococcal Candidate

Despite one recent setback, Astellas is continuing to expand its vaccines business through a new global deal for Affinivax's lead MAPS pneumococcal product, in a move that builds on earlier research links between the companies.

Vaccines Deals

Deal Watch: J.P. Morgan Brings Continued Brisk Pace Of Transactions

Allergan strikes a pair of deals for gastrointestinal and CNS candidates, while Amgen expands its reach in bispecific antibodies via a partnership with Immatics.

Deals M & A

Takeda Cements Norovirus Lead Through Vaccine Trial Start

Takeda has initiated dosing in the first field trial globally with a candidate vaccine for norovirus, maintaining its clear development lead in the area.

BioPharmaceutical United States

Allergy Deal Boosts Astellas's Pipeline, Allows Immunomic Refocus

Astellas is making good on its strategic intention to expand in vaccines and immunology, paying $300m upfront for worldwide rights to Immunomic's technology and pipeline for DNA vaccines against human allergies, in a deal that will also allow the US biotech to focus on other applications including oncology.

Immune Disorders Infectious Diseases
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • Japan
  • Parent & Subsidiaries
  • UMN Pharma Inc.
  • Senior Management
  • Tatsuyoshi Hirano, Pres. & CEO
  • Contact Info
  • UMN Pharma Inc.
    Phone: (81) 45-263-9200
    2-2-1 Minato Mirai Nishi-ku, 26F
    Landmark Tower
    Yokohama, 223-0057
    Japan
Advertisement
Advertisement
UsernamePublicRestriction

Register